Data as of 12:53pm ET
| +0.0825 / +3.47%|
The 2 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 7.30, with a high estimate of 8.20 and a low estimate of 6.40. The median estimate represents a +196.69% increase from the last price of 2.46.
The current consensus among 2 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.